logo

Ani Pharmaceuticals, Inc. (BPAX)



Trade BPAX now with
  Date
  Headline
5/8/2018 8:31:37 AM ANI Pharma Q1 GAAP EPS $0.19 Vs $0.10 Last Year
5/7/2018 8:31:23 AM ANI Pharmaceuticals Completes Acquisition Of Generic Products And Assets From Amneal/Impax
4/27/2018 7:32:44 PM ANI Pharmaceuticals Signs Definitive Agreements To Acquire Generic Products And Assets From Amneal/Impax
4/18/2018 8:32:52 AM ANI Gets FDA Approval For Its ANDA For Morphine Sulfate Oral Solution 10mg/5mL, 20mg/5mL And 100mg/5ml
4/4/2018 8:32:53 AM ANI Acquires ANDAs For 23 Previously Marketed Generic Drug Products From IDT Australia
2/27/2018 8:34:11 AM ANI Pharmaceuticals Q4 GAAP Loss Per Share $0.83; Adjusted Non-GAAP EPS $1.08
11/2/2017 9:07:47 AM ANI Pharmaceuticals, Inc. (ANIP) Has Raised Its 2017 EPS Estimate To 3.83 - 4.00 From 3.58 - 3.94
11/2/2017 9:06:55 AM ANI Pharmaceuticals, Inc. (ANIP) Has Lowered Its 2017 Revenue Estimate To $181 - $183 Mln From $181 - $190 Mln
11/3/2016 8:37:03 AM ANI Pharmaceuticals, Inc. (ANIP) Has Raised Its 2016 Revenue Estimate To $128 - $134 Mln From $119 - $134 Mln
8/4/2016 8:36:43 AM ANI Pharmaceuticals, Inc. (ANIP) Has Raised Its 2016 EPS Estimate To 4.00 - 4.25 From 3.54 - 3.91
4/4/2016 8:09:23 AM ANI Pharmaceuticals, Inc. (ANIP) Has Raised Its 2016 EPS Estimate To 3.54 - 3.91 From 2.94 - 3.31
4/4/2016 8:08:47 AM ANI Pharmaceuticals, Inc. (ANIP) Has Raised Its 2016 Revenue Estimate To $119 - $134 Mln From $105 - $120 Mln
11/3/2015 8:17:06 AM ANI Pharmaceuticals, Inc. (ANIP) Has Raised Its 2015 EPS Estimate To 2.83 - 2.96 From 2.44 - 2.50
11/3/2015 8:15:19 AM ANI Pharmaceuticals, Inc. (ANIP) Has Lowered Its 2015 Revenue Estimate To $75.5 Mln - $78.3 Mln From $82 Mln - $84 Mln
10/5/2015 8:02:12 AM ANI Pharmaceuticals, Inc. (ANIP) Announces $25 Mln Stock Buyback